Skip to main navigation
Invivyd
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • About Us
    • Management Team
    • Board of Directors
  • Our Approach
    • Coronaviruses Background
    • Pipeline
    • Publications
  • Clinical Trials
  • Investors & Media
  • Partners
  • Careers
  • Contact
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Feb 9, 2023
Document Date
Feb 9, 2023
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Invivyd
Issuer
INVIVYD, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Invivyd

For general inquiries:
info@invivyd.com

For medical information
inquiries:
medinfo@invivyd.com

781-819-0080

  • Follow
  • Follow

1601 Trapelo Rd.
Suite 178
Waltham, MA 02451

Privacy Policy   |   Terms of Use   |   Cookie Policy